Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2012
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysisP Gazzaniga, A Gradilone, E de Berardinis, et al.
Hepatology (Baltimore, Md.)|November 23, 2012
Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseasesTatyana V Masyuk, Brynn N Radtke, Angela J Stroope, et al.
Gastroenterology|April 20, 2010
Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKDSergio A Gradilone, Tatyana V Masyuk, Bing Q Huang, et al.
The American Journal of Pathology|November 12, 2013
Centrosomal abnormalities characterize human and rodent cystic cholangiocytes and are associated with Cdc25A overexpressionTatyana V Masyuk, Seung-Ok Lee, Brynn N Radtke, et al.
Journal of Cancer Research and Clinical Oncology|June 6, 2013
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?P Gazzaniga, C Raimondi, A Gradilone, et al.
Hepatology (Baltimore, Md.)|July 29, 2021
Histone Deacetylase Sirtuin 1 Promotes Loss of Primary Cilia in CholangiocarcinomaKishor Pant, Estanislao Peixoto, Seth Richard, et al.
Gastroenterology|December 14, 2011
Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver diseaseTatyana V Masyuk, Brynn N Radtke, Angela J Stroope, et al.
Hepatology (Baltimore, Md.)|February 7, 2018
MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinomaAdrian P Mansini, Maria J Lorenzo Pisarello, Kristen M Thelen, et al.
Pageof 9